Harm reduction treatment for substance use:
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Göttingen
Hogrefe
[2023]
|
Schriftenreihe: | Advances in Psychotherapy - Evidence-Based Practice
49 |
Schlagworte: | |
Online-Zugang: | Inhaltstext Inhaltsverzeichnis |
Beschreibung: | x, 116 Seiten Illustrationen, Diagramme 25.4 cm x 17.8 cm, 1 g |
ISBN: | 9780889375079 0889375070 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV048910263 | ||
003 | DE-604 | ||
005 | 20240205 | ||
007 | t | ||
008 | 230424s2023 gw a||| |||| 00||| eng d | ||
015 | |a 22,N51 |2 dnb | ||
016 | 7 | |a 1275857086 |2 DE-101 | |
020 | |a 9780889375079 |9 978-0-88937-507-9 | ||
020 | |a 0889375070 |9 0-88937-507-0 | ||
035 | |a (OCoLC)1394482535 | ||
035 | |a (DE-599)DNB1275857086 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE | ||
049 | |a DE-355 |a DE-11 | ||
084 | |a YH 3000 |0 (DE-625)153535:12905 |2 rvk | ||
084 | |a YH 3003 |0 (DE-625)153535:12909 |2 rvk | ||
084 | |a CU 3500 |0 (DE-625)19109: |2 rvk | ||
100 | 1 | |a Collins, Susan Elisabeth |e Verfasser |0 (DE-588)1300390832 |4 aut | |
245 | 1 | 0 | |a Harm reduction treatment for substance use |c Susan E. Collins, Seema L. Clifasefi |
264 | 1 | |a Göttingen |b Hogrefe |c [2023] | |
300 | |a x, 116 Seiten |b Illustrationen, Diagramme |c 25.4 cm x 17.8 cm, 1 g | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Advances in Psychotherapy - Evidence-Based Practice |v 49 | |
650 | 0 | 7 | |a Suchtkrankenhilfe |0 (DE-588)4126446-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Drogentherapie |0 (DE-588)4122122-9 |2 gnd |9 rswk-swf |
653 | |a 10: Psychotherapie und Klinische Psychologie | ||
653 | |a 15: Psychiatrie | ||
653 | |a Addiction | ||
653 | |a Harm reduction approaches | ||
653 | |a drug use | ||
653 | |a evidence-based therapy | ||
689 | 0 | 0 | |a Suchtkrankenhilfe |0 (DE-588)4126446-0 |D s |
689 | 0 | 1 | |a Drogentherapie |0 (DE-588)4122122-9 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Clifasefi, Seema Lisa |e Verfasser |0 (DE-588)1300391243 |4 aut | |
710 | 2 | |a Hogrefe Publishing GmbH |0 (DE-588)1065422652 |4 pbl | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe, PDF |z 9781616765071 |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe, EPUB |z 9781613345078 |
856 | 4 | 2 | |m X:MVB |q text/html |u http://deposit.dnb.de/cgi-bin/dokserv?id=6a6a095fc99849d6abc4715baa16bd76&prov=M&dok_var=1&dok_ext=htm |3 Inhaltstext |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034174481&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-034174481 |
Datensatz im Suchindex
_version_ | 1804185081349144576 |
---|---|
adam_text | ACKNOWLEDGMENTS
.........................................................................................
V
PREFACE
..........................................................................................................
IX
1
DESCRIPTION
........................................................................................
1
1.1
TERMINOLOGY
AND
DEFINITIONS
.............................................................
2
1.1.1
HARM
REDUCTION
HEARTSET
IS
FOUNDATIONAL
.......................................
2
1.1.2
HARM
REDUCTION
MINDSET
IS
PRAGMATIC
.............................................
2
1.1.3
HARM
REDUCTION
ACROSS
ECOLOGICAL
SYSTEMS
.....................................
3
1.2
APPLYING
HARM
REDUCTION
IN
CLINICAL
WORK
........................................
3
1.2.1
ACCEPTING
SUBSTANCE
USE
IS
HERE
TO
STAY
........................................
3
1.2.2
ACKNOWLEDGING
REASONS
FOR
CLIENTS
USE
..........................................
3
1.2.3
RECOGNIZING
SUBSTANCE-RELATED
HARM
IS
SHAPED
BY
SYSTEMS
.........
4
1.2.4
SUPPORTING
CLIENTS
OWN
STEPS
TOWARD
HARM
REDUCTION
.................
6
1.2.5
WORKING
TOWARD
SOCIAL
JUSTICE
AND
RACIAL
EQUITY
............................
7
1.3
RATIONALE
FOR
HARM
REDUCTION
...........................................................
8
1.3.1
ABSTINENCE-ONLY
APPROACHES
ARE
DISEMPOWERING
......................
8
1.3.2
ABSTINENCE-ONLY
APPROACHES
DO
NOT
CONSISTENTLY
ENGAGE
..............
10
1.3.3
HARM
REDUCTION
APPROACHES
ARE
EFFECTIVE
.......................................
11
1.4
THE
HARM
REDUCTION
TREATMENT
MODEL
.............................................
12
1.5
RELATED
AND
FOUNDATIONAL
TREATMENT
MODELS
...................................
14
1.5.1
CONTROLLED
DRINKING
........................................................................
15
1.5.2
BRIEF
INTERVENTIONS
IN
HEALTH
CARE
SETTINGS
......................................
16
1.5.3
PERSONALIZED
NORMATIVE
FEEDBACK
INTERVENTIONS
..............................
16
1.5.4
MOTIVATIONAL
INTERVIEWING
..................................................................
17
1.5.5
GUIDED
SELF-CHANGE
..........................................................................
17
1.5.6
HARM
REDUCTION
PSYCHOTHERAPY
........................................................
18
1.6
CONCLUSIONS
......................................................................................
19
2
THEORIES
AND
MODELS
........................................................................
20
2.1
PHARMACOLOGICAL
TREATMENT
FOR
HARM
REDUCTION
..............................
20
2.2
BEHAVIORAL
HARM
REDUCTION
TREATMENT
.............................................
22
2.2.1
HART
MINDSET
...................................................................................
23
2.2.2
HART
HEARTSET
...................................................................................
25
2.2.3
HART
COMPONENTS
............................................................................
26
2.3
WHAT
HART
IS
NOT
...................................................................................
29
3
ASSESSMENT
AND
TREATMENT
INDICATIONS
.........................................
32
3.1
TREATMENT
INDICATION
........................................................................
32
3.2
PREPARATION
FOR
HART
........................................................................
33
3.2.1
REFLECTING
ON
AND
READYING
YOUR
PRACTICE
SETTING
............................
33
3.2.2
PREPARING
TO
NAVIGATE
SYSTEMS
FOR
AND
WITH
CLIENTS
.......................
36
3.3
ASSESSMENT
OF
HART
EFFICACY
ON
KEY
OUTCOMES
.............................
40
3.3.1
ASSESSMENT
OF
SAFER-USE
STRATEGIES
AND
HARM
REDUCTION
GOAL
SETTING
........................................................................
40
3.3.2
ASSESSMENT
OF
SUBSTANCE
USE
OUTCOMES
.........................................
42
3.3.3
LAB
TESTING
AND
BIOMARKERS
................................................................
43
3.3.4
MEASURES
OF
QOL
OUTCOMES
................................................................
44
3.3.5
MEASURES
FOR
UTILIZATION
AND
COST
ANALYSIS
.......................................
44
3.3.6
TREATMENT
INTEGRITY
MATERIALS
AND
MEASURES
....................................
45
4
HART
IMPLEMENTATION
........................................................................
46
4.1
METHOD
OF
APPROACH
...........................................................................
46
4.1.1
HART
MINDSET
....................................................................................
46
4.1.2
HART
HEARTSET
....................................................................................
51
4.1.3
HART
COMPONENTS
AND
THEIR
INTEGRATION
IN
INITIAL
AND
FOLLOW-UP
SESSIONS
....................................
63
4.1.4
AUXILIARY
HART
COMPONENTS
...............................................................
78
4.2
HART
EFFICACY
AND
PROGNOSIS
..............................................................
84
4.2.1
BEHAVIORAL
HARM
REDUCTION
TREATMENT
FOR
AUD
.................................
84
4.2.2
COMBINED
PHARMACOTHERAPY
AND
BEHAVIORAL
TREATMENT
.................
86
4.3
PROBLEMS
IN
CARRYING
OUT
THE
APPROACHES
.........................................
86
4.4
DIVERSITY
ISSUES
..................................................................................
88
5
AFTERWORD
...........................................................................................
90
6
CASE
VIGNETTES
..................................................................................
91
7
FURTHER
READING
.................................................................................
95
8
REFERENCES
.........................................................................................
97
9
APPENDIX:
TOOLS
AND
RESOURCES
........................................................
108
|
adam_txt |
ACKNOWLEDGMENTS
.
V
PREFACE
.
IX
1
DESCRIPTION
.
1
1.1
TERMINOLOGY
AND
DEFINITIONS
.
2
1.1.1
HARM
REDUCTION
HEARTSET
IS
FOUNDATIONAL
.
2
1.1.2
HARM
REDUCTION
MINDSET
IS
PRAGMATIC
.
2
1.1.3
HARM
REDUCTION
ACROSS
ECOLOGICAL
SYSTEMS
.
3
1.2
APPLYING
HARM
REDUCTION
IN
CLINICAL
WORK
.
3
1.2.1
ACCEPTING
SUBSTANCE
USE
IS
HERE
TO
STAY
.
3
1.2.2
ACKNOWLEDGING
REASONS
FOR
CLIENTS
'
USE
.
3
1.2.3
RECOGNIZING
SUBSTANCE-RELATED
HARM
IS
SHAPED
BY
SYSTEMS
.
4
1.2.4
SUPPORTING
CLIENTS
'
OWN
STEPS
TOWARD
HARM
REDUCTION
.
6
1.2.5
WORKING
TOWARD
SOCIAL
JUSTICE
AND
RACIAL
EQUITY
.
7
1.3
RATIONALE
FOR
HARM
REDUCTION
.
8
1.3.1
ABSTINENCE-ONLY
APPROACHES
ARE
DISEMPOWERING
.
8
1.3.2
ABSTINENCE-ONLY
APPROACHES
DO
NOT
CONSISTENTLY
ENGAGE
.
10
1.3.3
HARM
REDUCTION
APPROACHES
ARE
EFFECTIVE
.
11
1.4
THE
HARM
REDUCTION
TREATMENT
MODEL
.
12
1.5
RELATED
AND
FOUNDATIONAL
TREATMENT
MODELS
.
14
1.5.1
"
CONTROLLED
DRINKING
"
.
15
1.5.2
BRIEF
INTERVENTIONS
IN
HEALTH
CARE
SETTINGS
.
16
1.5.3
PERSONALIZED
NORMATIVE
FEEDBACK
INTERVENTIONS
.
16
1.5.4
MOTIVATIONAL
INTERVIEWING
.
17
1.5.5
GUIDED
SELF-CHANGE
.
17
1.5.6
HARM
REDUCTION
PSYCHOTHERAPY
.
18
1.6
CONCLUSIONS
.
19
2
THEORIES
AND
MODELS
.
20
2.1
PHARMACOLOGICAL
TREATMENT
FOR
HARM
REDUCTION
.
20
2.2
BEHAVIORAL
HARM
REDUCTION
TREATMENT
.
22
2.2.1
HART
MINDSET
.
23
2.2.2
HART
HEARTSET
.
25
2.2.3
HART
COMPONENTS
.
26
2.3
WHAT
HART
IS
NOT
.
29
3
ASSESSMENT
AND
TREATMENT
INDICATIONS
.
32
3.1
TREATMENT
INDICATION
.
32
3.2
PREPARATION
FOR
HART
.
33
3.2.1
REFLECTING
ON
AND
READYING
YOUR
PRACTICE
SETTING
.
33
3.2.2
PREPARING
TO
NAVIGATE
SYSTEMS
FOR
AND
WITH
CLIENTS
.
36
3.3
ASSESSMENT
OF
HART
EFFICACY
ON
KEY
OUTCOMES
.
40
3.3.1
ASSESSMENT
OF
SAFER-USE
STRATEGIES
AND
HARM
REDUCTION
GOAL
SETTING
.
40
3.3.2
ASSESSMENT
OF
SUBSTANCE
USE
OUTCOMES
.
42
3.3.3
LAB
TESTING
AND
BIOMARKERS
.
43
3.3.4
MEASURES
OF
QOL
OUTCOMES
.
44
3.3.5
MEASURES
FOR
UTILIZATION
AND
COST
ANALYSIS
.
44
3.3.6
TREATMENT
INTEGRITY
MATERIALS
AND
MEASURES
.
45
4
HART
IMPLEMENTATION
.
46
4.1
METHOD
OF
APPROACH
.
46
4.1.1
HART
MINDSET
.
46
4.1.2
HART
HEARTSET
.
51
4.1.3
HART
COMPONENTS
AND
THEIR
INTEGRATION
IN
INITIAL
AND
FOLLOW-UP
SESSIONS
.
63
4.1.4
AUXILIARY
HART
COMPONENTS
.
78
4.2
HART
EFFICACY
AND
PROGNOSIS
.
84
4.2.1
BEHAVIORAL
HARM
REDUCTION
TREATMENT
FOR
AUD
.
84
4.2.2
COMBINED
PHARMACOTHERAPY
AND
BEHAVIORAL
TREATMENT
.
86
4.3
PROBLEMS
IN
CARRYING
OUT
THE
APPROACHES
.
86
4.4
DIVERSITY
ISSUES
.
88
5
AFTERWORD
.
90
6
CASE
VIGNETTES
.
91
7
FURTHER
READING
.
95
8
REFERENCES
.
97
9
APPENDIX:
TOOLS
AND
RESOURCES
.
108 |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
author | Collins, Susan Elisabeth Clifasefi, Seema Lisa |
author_GND | (DE-588)1300390832 (DE-588)1300391243 |
author_facet | Collins, Susan Elisabeth Clifasefi, Seema Lisa |
author_role | aut aut |
author_sort | Collins, Susan Elisabeth |
author_variant | s e c se sec s l c sl slc |
building | Verbundindex |
bvnumber | BV048910263 |
classification_rvk | YH 3000 YH 3003 CU 3500 |
ctrlnum | (OCoLC)1394482535 (DE-599)DNB1275857086 |
discipline | Psychologie Medizin |
discipline_str_mv | Psychologie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02329nam a2200553 cb4500</leader><controlfield tag="001">BV048910263</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240205 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">230424s2023 gw a||| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">22,N51</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1275857086</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780889375079</subfield><subfield code="9">978-0-88937-507-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0889375070</subfield><subfield code="9">0-88937-507-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1394482535</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1275857086</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YH 3000</subfield><subfield code="0">(DE-625)153535:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YH 3003</subfield><subfield code="0">(DE-625)153535:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CU 3500</subfield><subfield code="0">(DE-625)19109:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Collins, Susan Elisabeth</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1300390832</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Harm reduction treatment for substance use</subfield><subfield code="c">Susan E. Collins, Seema L. Clifasefi</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Göttingen</subfield><subfield code="b">Hogrefe</subfield><subfield code="c">[2023]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">x, 116 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">25.4 cm x 17.8 cm, 1 g</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in Psychotherapy - Evidence-Based Practice</subfield><subfield code="v">49</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Suchtkrankenhilfe</subfield><subfield code="0">(DE-588)4126446-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogentherapie</subfield><subfield code="0">(DE-588)4122122-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">10: Psychotherapie und Klinische Psychologie</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">15: Psychiatrie</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Addiction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Harm reduction approaches</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug use</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">evidence-based therapy</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Suchtkrankenhilfe</subfield><subfield code="0">(DE-588)4126446-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Drogentherapie</subfield><subfield code="0">(DE-588)4122122-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Clifasefi, Seema Lisa</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1300391243</subfield><subfield code="4">aut</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Hogrefe Publishing GmbH</subfield><subfield code="0">(DE-588)1065422652</subfield><subfield code="4">pbl</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, PDF</subfield><subfield code="z">9781616765071</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, EPUB</subfield><subfield code="z">9781613345078</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="q">text/html</subfield><subfield code="u">http://deposit.dnb.de/cgi-bin/dokserv?id=6a6a095fc99849d6abc4715baa16bd76&prov=M&dok_var=1&dok_ext=htm</subfield><subfield code="3">Inhaltstext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034174481&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034174481</subfield></datafield></record></collection> |
id | DE-604.BV048910263 |
illustrated | Illustrated |
index_date | 2024-07-03T21:53:07Z |
indexdate | 2024-07-10T09:49:34Z |
institution | BVB |
institution_GND | (DE-588)1065422652 |
isbn | 9780889375079 0889375070 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034174481 |
oclc_num | 1394482535 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-11 |
owner_facet | DE-355 DE-BY-UBR DE-11 |
physical | x, 116 Seiten Illustrationen, Diagramme 25.4 cm x 17.8 cm, 1 g |
publishDate | 2023 |
publishDateSearch | 2023 |
publishDateSort | 2023 |
publisher | Hogrefe |
record_format | marc |
series2 | Advances in Psychotherapy - Evidence-Based Practice |
spelling | Collins, Susan Elisabeth Verfasser (DE-588)1300390832 aut Harm reduction treatment for substance use Susan E. Collins, Seema L. Clifasefi Göttingen Hogrefe [2023] x, 116 Seiten Illustrationen, Diagramme 25.4 cm x 17.8 cm, 1 g txt rdacontent n rdamedia nc rdacarrier Advances in Psychotherapy - Evidence-Based Practice 49 Suchtkrankenhilfe (DE-588)4126446-0 gnd rswk-swf Drogentherapie (DE-588)4122122-9 gnd rswk-swf 10: Psychotherapie und Klinische Psychologie 15: Psychiatrie Addiction Harm reduction approaches drug use evidence-based therapy Suchtkrankenhilfe (DE-588)4126446-0 s Drogentherapie (DE-588)4122122-9 s DE-604 Clifasefi, Seema Lisa Verfasser (DE-588)1300391243 aut Hogrefe Publishing GmbH (DE-588)1065422652 pbl Erscheint auch als Online-Ausgabe, PDF 9781616765071 Erscheint auch als Online-Ausgabe, EPUB 9781613345078 X:MVB text/html http://deposit.dnb.de/cgi-bin/dokserv?id=6a6a095fc99849d6abc4715baa16bd76&prov=M&dok_var=1&dok_ext=htm Inhaltstext DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034174481&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Collins, Susan Elisabeth Clifasefi, Seema Lisa Harm reduction treatment for substance use Suchtkrankenhilfe (DE-588)4126446-0 gnd Drogentherapie (DE-588)4122122-9 gnd |
subject_GND | (DE-588)4126446-0 (DE-588)4122122-9 |
title | Harm reduction treatment for substance use |
title_auth | Harm reduction treatment for substance use |
title_exact_search | Harm reduction treatment for substance use |
title_exact_search_txtP | Harm reduction treatment for substance use |
title_full | Harm reduction treatment for substance use Susan E. Collins, Seema L. Clifasefi |
title_fullStr | Harm reduction treatment for substance use Susan E. Collins, Seema L. Clifasefi |
title_full_unstemmed | Harm reduction treatment for substance use Susan E. Collins, Seema L. Clifasefi |
title_short | Harm reduction treatment for substance use |
title_sort | harm reduction treatment for substance use |
topic | Suchtkrankenhilfe (DE-588)4126446-0 gnd Drogentherapie (DE-588)4122122-9 gnd |
topic_facet | Suchtkrankenhilfe Drogentherapie |
url | http://deposit.dnb.de/cgi-bin/dokserv?id=6a6a095fc99849d6abc4715baa16bd76&prov=M&dok_var=1&dok_ext=htm http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034174481&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT collinssusanelisabeth harmreductiontreatmentforsubstanceuse AT clifasefiseemalisa harmreductiontreatmentforsubstanceuse AT hogrefepublishinggmbh harmreductiontreatmentforsubstanceuse |